Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€112.52
19.01.18
€140.00
04.11.21
42.01%
05.11.21

stratec 
14.08.19 50%
buy
GW Pharmaceuticals plc ADR

Start price
Target price
Perf. (%)
€80.50
24.03.20
€180.00
04.11.21
127.33%
24.06.21

Subdi 
24.03.20 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€23.43
23.09.20
€36.00
04.11.21
58.26%
21.06.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Fair valuation
High Investments for future growth
Mori8 
23.09.20 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€13.38
08.03.21
€15.00
13.62%
10.03.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
08.03.21 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€5.20
07.11.20
€6.40
23.49%
30.11.20

Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
gerihouse 
07.11.20 50%
buy
Acceleron Pharma Inc.

Start price
Target price
Perf. (%)
€42.18
31.03.19
€45.10
12.09.20
82.54%
12.09.20

melinda 
18.08.19 50%
buy
Nuvasive Inc.

Start price
Target price
Perf. (%)
€58.90
06.05.19
€64.04
19.11.19
10.36%
19.11.19

melinda 
18.08.19 50%
buy
Orpea Nom.

Start price
Target price
Perf. (%)
€103.90
17.03.19
€110.00
30.07.19
8.18%
30.07.19

Could be worthwhile Investment >10% per year
melinda 
18.08.19 50%
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€94.00
02.02.19
€103.00
23.07.19
10.00%
23.07.19

Could be worthwhile Investment >10% per year
melinda 
18.08.19 50%
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€94.00
02.02.19
€103.00
23.07.19
10.00%
23.07.19

Could be worthwhile Investment >10% per year
melinda 
18.08.19 50%
buy
Repligen Corp.

Start price
Target price
Perf. (%)
€59.62
26.04.19
€63.14
11.06.19
12.47%
11.06.19

Could be worthwhile Investment >10% per year
melinda 
18.08.19 50%
buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€56.64
05.05.19
€69.45
11.06.19
55.44%
11.06.19

melinda 
18.08.19 50%
buy
Global Blood Therapeutics Inc

Start price
Target price
Perf. (%)
€45.09
08.02.19
€49.61
11.06.19
11.93%
11.06.19

melinda 
18.08.19 50%
buy
Blueprint Medicines Corp

Start price
Target price
Perf. (%)
€76.30
26.05.19
€79.38
06.06.19
4.18%
06.06.19

melinda 
18.08.19 50%
buy
Ascendis Ph.sp.adr 1 Dk 1

Start price
Target price
Perf. (%)
€105.89
31.03.19
€117.26
28.05.19
10.98%
28.05.19

Could be worthwhile Investment >10% per year
melinda 
18.08.19 50%
buy
Healthequity Inc.

Start price
Target price
Perf. (%)
€69.69
17.02.19
€74.87
01.03.19
7.60%
01.03.19

melinda 
18.08.19 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€6.14
24.01.19
€10.00
05.02.19
63.36%
05.02.19

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
05.08.19 50%
buy
Pra Health

Start price
Target price
Perf. (%)
€89.79
20.01.19
€95.16
31.01.19
5.98%
31.01.19

melinda 
18.08.19 50%
buy
Viatris Inc.

Start price
Target price
Perf. (%)
€26.37
12.01.19
€27.24
30.01.19
5.28%
30.01.19

melinda 
18.08.19 50%
buy
Viatris Inc.

Start price
Target price
Perf. (%)
€26.37
12.01.19
€27.24
30.01.19
5.28%
30.01.19

melinda 
18.08.19 50%
buy
Myokardia Inc

Start price
Target price
Perf. (%)
€51.22
16.10.18
€57.73
08.11.18
13.07%
08.11.18

melinda 
18.08.19 50%
buy
Ionis Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€40.27
11.10.18
€45.55
31.10.18
13.69%
31.10.18

melinda 
18.08.19 50%
buy
Myokardia Inc

Start price
Target price
Perf. (%)
€47.21
12.10.18
€51.41
16.10.18
8.98%
16.10.18

melinda 
18.08.19 50%
buy
Acadia Healthcare

Start price
Target price
Perf. (%)
€32.26
18.09.18
€34.28
09.10.18
7.44%
09.10.18

melinda 
18.08.19 50%
buy
Orpea Nom.

Start price
Target price
Perf. (%)
€112.70
19.08.18
€117.50
12.09.18
4.61%
12.09.18

Could be worthwhile Investment >10% per year
melinda 
18.08.19 50%